Support Our Coronavirus Research

Addressing a Pandemic in Real Time

We are rising to this moment the way we have always approached challenges: with fearless science, open collaboration, and unshakeable focus.
Join us.

COVID-19 Research at Fred Hutch

We’ve been studying viruses for as long as we’ve been studying cancer — because cancer and our bodies’ defenses against infection are closely linked. When the novel coronavirus began to spread in China, our scientists responded immediately. When it reached the U.S., we were ready to take the lead — tracking the spread of the virus; protecting patients; expanding testing capacity; and advising local, national, and global policymakers on how and where the virus is spreading and how to flatten the curve.

Now we’re studying people with COVID-19, and those at high risk, to investigate how the immune system responds to the virus and pinpoint antibodies that target it. We’re creating a clinic to conduct therapy trials and learn about long-term effects for patients. And we’re partnering with other cancer centers to explore the impact of the virus on cancer patients. From data science to virology, we’ve activated our broad expertise to halt the spread of COVID-19, find treatments, and develop vaccines.

Fueling the Leading Edge of COVID-19 Research

To end this pandemic, and prevent future ones, we need to address it from multiple angles. Our expertise — in everything from basic science to vaccine development — is uniquely suited to this once-in-a-generation challenge.

Our priorities include:

  • Developing and evaluating rapid testing and point-of-care tests to increase availability and speed results.
  • Discovering antibodies in people infected with the coronavirus to inform new therapeutics and vaccines.
  • Creating a one-of-a-kind COVID-19 Clinical Research Center to conduct drug trials and other clinical research.
  • Developing vaccines that will provide lifetime protection no matter how many times the virus mutates.
  • Decoding how coronaviruses evolve so we can empower our immune systems to defend against them.
  • Understanding how to safely turn down the dial on physical distancing so people and businesses can ramp up activities.
  • Reducing the pandemic's disproportionate effect on communities of color and other health inequities.

We’re raising $10 million to support COVID-19 research, and we need your partnership.

Charitable support from people like you allows us to move faster and explore the newest, most daring ideas. By fostering innovation early in the research process, you make it possible for us to build the evidence we need to secure government funding, foundation grants, and industry partnerships — and to turn promising ideas into proven solutions that will halt the pandemic and save lives worldwide.

Thank you for your belief in the power of research.

Dr. Larry Corey
Fred Hutch is part of the COVID-19 Prevention Network, a national collaboration to speed the development of vaccines to stop the coronavirus. Fred Hutch virologist and former president and director, Dr. Larry Corey, is head of operations for the five or more clinical trials, which will involve 30,000 volunteers each.

Support COVID-19 Research

$6.8 M

Raised to Date
Thank you for your generous support!


More than half are new donors.

$10 M

Summer 2020 Goal
To support COVID-19 research.

Why Does Fred Hutch Study Viruses?

Our pioneering work in bone marrow transplantation revealed the urgent need to protect transplant patients from deadly infections, which launched our quest to gain an in-depth understanding of the immune system.

Today, we’re known for our expertise in virology and infectious disease. We are working in the laboratory, the clinic, and the cloud to find better ways to detect, prevent, and treat viruses and other infections to protect patients and communities. Working across disciplines, we are studying how HIV and other viruses evolve, learning how pathogens cause cancers, and developing and advancing treatments that harness patients’ own immune systems to fight disease. We track epidemics to guide public health officials’ strategies to contain outbreaks of diseases like Zika, Ebola, and now COVID-19. And we’re on the leading edge of developing vaccines to prevent HIV, with active research projects in Kenya, South Africa, Uganda, and more than 40 other countries. 

Your gift to support our coronavirus response will have immediate and long-term impact. Please give today.

HVTN employee working in the lab

Infectious Disease Research at the Hutch

Our infectious disease researchers study the epidemiology of infectious diseases, investigate emerging infectious diseases, develop novel diagnostics, and conduct clinical trials on potential new treatments.

Learn More
Dr. Elizabeth Halloran

COVID-19 Research

Fred Hutch researchers are working together to stop this pandemic and prevent the next one — people like Dr. Elizabeth Halloran, who has turned her expertise in statistics and dynamic modeling to estimate the potential spread of COVID-19 under various scenarios, advise policymakers, and evaluate potential vaccines and vaccination strategies.    

Learn More
Last Modified, July 29, 2020